Ventas, Inc. (VTR)
- Previous Close
43.36 - Open
43.34 - Bid 43.82 x 900
- Ask 43.85 x 800
- Day's Range
43.40 - 43.90 - 52 Week Range
39.33 - 50.99 - Volume
110,721 - Avg. Volume
2,475,496 - Market Cap (intraday)
17.705B - Beta (5Y Monthly) 1.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.08 - Earnings Date May 1, 2024
- Forward Dividend & Yield 1.80 (4.15%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
51.50
Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties. The Ventas portfolio is composed of senior housing communities, outpatient medical buildings, research centers and healthcare facilities in North America and the United Kingdom. The Company benefits from a seasoned team of talented professionals who share a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.
www.ventasreit.com486
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: VTR
Performance Overview: VTR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTR
Valuation Measures
Market Cap
17.52B
Enterprise Value
30.70B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.91
Price/Book (mrq)
1.85
Enterprise Value/Revenue
6.82
Enterprise Value/EBITDA
15.75
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.91%
Return on Assets (ttm)
1.65%
Return on Equity (ttm)
-0.30%
Revenue (ttm)
4.5B
Net Income Avi to Common (ttm)
-40.97M
Diluted EPS (ttm)
-0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
508.79M
Total Debt/Equity (mrq)
138.98%
Levered Free Cash Flow (ttm)
953.28M
Research Analysis: VTR
Company Insights: VTR
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: VTR
Analyst Report: Ventas, Inc.
Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
RatingPrice TargetAnalyst Report: Ventas, Inc.
Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
RatingPrice TargetAnalyst Report: Ventas Inc
Ventas Inc. is a real estate investment trust that invests primarily in real estate serving the healthcare industry. The company acquires, develops, leases, and manages about 1,400 senior housing and medical office properties in the U.S., Canada, and the U.K. Currently, senior housing properties account for about 60% of VTR's portfolio and medical and research assets for about 30% of the portfolio. These offices are located in 31 states, and 95% are affiliated with hospitals or health systems. The company acquired 153 new properties in 1H23 in a loan-to-own transaction. In 2023, about 40% of NOI comes from SHOP assets and 30% from medical offices and research properties. The company was founded in 1998 as a spinoff of Vencor, a healthcare services company. VTR also has an asset management business (VIM) with $5.5 billion under management. VTR shares are a component of the S&P 500. The company's market cap is $17.2 billion.
RatingPrice TargetMarket Update: PWR, PXD, VTR, KHC
Stocks fell on Thursday on hotter-than-expected inflation readings. In February, headline PPI rose 0.6%, up from 0.2% in January and ahead of the expected 0.3% increase -- with nearly two-thirds of the increase attributed to a rise in prices for final-demand goods. A 4.4% rise in energy prices during the month was the main factor in the increase in final-demand goods, contributing over one-third of the increase. PPI rose 0.4% in February, down from 0.6% last month but ahead of the expected 0.2% increase. U.S. retail sales in February were up 0.6%, following the 0.8% decline in January. The Dow fell 0.2%, the S&P 500 was down 0.3%, and the Nasdaq lost 0.1%. Crude oil traded above $81 per barrel, while gold fell $18 to $2162 per ounce.